The latest thoracic oncology news
On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle for…
Coexisting lung cancer and pulmonary tuberculosis (LC-PTB) is clinically challenging in diagnosis and treatment, and…
For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there’s new…
For decades, lung cancer has been associated with stigma, anxiety, and loss. Advances in screening,…
A team of scientists has developed a simple method for automated manufacturing of lung organoids,…
In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute, USA,…
Two companion studies published in Cancer Research identify distinct but complementary approaches to overcoming drug resistance in…
Two companion studies published in Cancer Research identify distinct but complementary approaches to overcoming drug resistance in…
University of Texas at Dallas (USA) researchers have developed biosensor technology that, when combined with…
ESMO Special Part 2! Are you ready for ESMO Bingo? Welcome to Episode 9 of the third series of The Oncology Journal Club. Dr Kate Clarke takes over hosting duties as Professor Craig Underhill unpacks the GU and lung highlights. With witty commentary and a London Global Cancer Week sneak preview by Professor Christopher Jackson.